Literature DB >> 24027319

Dynamic viral dissemination in mice infected with yellow fever virus strain 17D.

Andrea K Erickson1, Julie K Pfeiffer.   

Abstract

Arboviruses such as yellow fever virus (YFV) are transmitted between arthropod vectors and vertebrate hosts. While barriers limiting arbovirus population diversity have been observed in mosquitoes, whether barriers exist in vertebrate hosts is unclear. To investigate whether arboviruses encounter bottlenecks during dissemination in the vertebrate host, we infected immunocompetent mice and immune-deficient mice lacking alpha/beta interferon (IFN-α/β) receptors (IFNAR⁻/⁻ mice) with a pool of genetically marked viruses to evaluate dissemination and host barriers. We used the live attenuated vaccine strain YFV-17D, which contains many mutations compared with virulent YFV. We found that intramuscularly injected immunocompetent mice did not develop disease and that viral dissemination was restricted. Conversely, 32% of intramuscularly injected IFNAR⁻/⁻ mice developed disease. By following the genetically marked viruses over time, we found broad dissemination in IFNAR⁻/⁻ mice followed by clearance. The patterns of viral dissemination were similar in mice that developed disease and mice that did not develop disease. Unlike our previous results with poliovirus, these results suggest that YFV-17D encounters no major barriers during dissemination within a vertebrate host in the absence of the type I IFN response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24027319      PMCID: PMC3807901          DOI: 10.1128/JVI.02149-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population.

Authors:  Marco Vignuzzi; Jeffrey K Stone; Jamie J Arnold; Craig E Cameron; Raul Andino
Journal:  Nature       Date:  2005-12-04       Impact factor: 49.962

2.  The Behavior of the Virus of Yellow Fever in Monkeys and Mice.

Authors:  A W Sellards
Journal:  Proc Natl Acad Sci U S A       Date:  1931-06       Impact factor: 11.205

3.  Homogeneity of yellow fever virus strains isolated during an epidemic and a post-epidemic period in West Africa.

Authors:  M R Pisano; J Nicoli; H Tolou
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  SUSCEPTIBILITY OF WHITE MICE TO THE VIRUS OF YELLOW FEVER.

Authors:  M Theiler
Journal:  Science       Date:  1930-04-04       Impact factor: 47.728

5.  The in vivo differentiation of strains of yellow fever virus in mice.

Authors:  R Fitzgeorge; C J Bradish
Journal:  J Gen Virol       Date:  1980-01       Impact factor: 3.891

6.  E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.

Authors:  Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

7.  Retrograde transport of intact poliovirus through the axon via the fast transport system.

Authors:  S Ohka; W X Yang; E Terada; K Iwasaki; A Nomoto
Journal:  Virology       Date:  1998-10-10       Impact factor: 3.616

8.  A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease.

Authors:  Rachel L Graham; Michelle M Becker; Lance D Eckerle; Meagan Bolles; Mark R Denison; Ralph S Baric
Journal:  Nat Med       Date:  2012-11-11       Impact factor: 53.440

9.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

10.  IMMUNITY TO YELLOW FEVER ENCEPHALITIS OF MONKEYS AND MICE IMMUNIZED BY NEURAL AND EXTRANEURAL ROUTES.

Authors:  J P Fox
Journal:  J Exp Med       Date:  1943-06-01       Impact factor: 14.307

View more
  15 in total

1.  Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system.

Authors:  Lauren N Luethy; Andrea K Erickson; Palmy R Jesudhasan; Mine Ikizler; Terence S Dermody; Julie K Pfeiffer
Journal:  Virology       Date:  2015-10-16       Impact factor: 3.616

2.  Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.

Authors:  Lisa Miorin; Maudry Laurent-Rolle; Giuseppe Pisanelli; Pierre Hendrick Co; Randy A Albrecht; Adolfo García-Sastre; Juliet Morrison
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

Review 3.  Antagonism of type I interferon by flaviviruses.

Authors:  Lisa Miorin; Ana M Maestre; Ana Fernandez-Sesma; Adolfo García-Sastre
Journal:  Biochem Biophys Res Commun       Date:  2017-05-31       Impact factor: 3.575

4.  Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production.

Authors:  Margarita V Rangel; Nicholas Catanzaro; Sara A Thannickal; Kelly A Crotty; Maria G Noval; Katherine E E Johnson; Elodie Ghedin; Helen M Lazear; Kenneth A Stapleford
Journal:  J Virol       Date:  2021-11-10       Impact factor: 6.549

Review 5.  Current status and future prospects of yellow fever vaccines.

Authors:  Andrew S Beck; Alan D T Barrett
Journal:  Expert Rev Vaccines       Date:  2015-09-14       Impact factor: 5.217

6.  Rapid Dissemination and Monopolization of Viral Populations in Mice Revealed Using a Panel of Barcoded Viruses.

Authors:  Broc T McCune; Matthew R Lanahan; Benjamin R tenOever; Julie K Pfeiffer
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

7.  Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.

Authors:  Nicholas Hernandez; Giorgia Bucciol; Leen Moens; Jérémie Le Pen; Mohammad Shahrooei; Ekaterini Goudouris; Afshin Shirkani; Majid Changi-Ashtiani; Hassan Rokni-Zadeh; Stephen J Seligman; Laurent Abel; Paul Hertzog; Nico Marr; Reinaldo de Menezes Martins; Isabelle Meyts; Qian Zhang; Margaret R MacDonald; Charles M Rice; Jean-Laurent Casanova; Emmanuelle Jouanguy; Xavier Bossuyt; Esra Hazar Sayar; Ismail Reisli; Alain Lefevre-Utile; Dick Zijlmans; Andrea Jurado; Ruben Pholien; Scott Drutman; Serkan Belkaya; Aurelie Cobat; Robbert Boudewijns; Dirk Jochmans; Johan Neyts; Yoann Seeleuthner; Lazaro Lorenzo-Diaz; Chibuzo Enemchukwu; Ian Tietjen; Hans-Heinrich Hoffmann; Mana Momenilandi; Laura Pöyhönen; Marilda M Siqueira; Sheila M Barbosa de Lima; Denise C de Souza Matos; Akira Homma; Maria de Lourdes S Maia; Tamiris Azamor da Costa Barros; Patricia Mouta Nunes de Oliveira; Emersom Ciclini Mesquita; Rik Gijsbers; Shen-Ying Zhang
Journal:  J Exp Med       Date:  2019-07-03       Impact factor: 14.307

8.  Porcine RING Finger Protein 114 Inhibits Classical Swine Fever Virus Replication via K27-Linked Polyubiquitination of Viral NS4B.

Authors:  Yuexiu Zhang; Huawei Zhang; Guang-Lai Zheng; Qian Yang; Shaoxiong Yu; Jinghan Wang; Su Li; Lian-Feng Li; Hua-Ji Qiu
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

9.  Limited evolution of the yellow fever virus 17d in a mouse infection model.

Authors:  Dieudonné Buh Kum; Niraj Mishra; Bram Vrancken; Hendrik Jan Thibaut; Annelies Wilder-Smith; Philippe Lemey; Johan Neyts; Kai Dallmeier
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

10.  A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice.

Authors:  Robbert Boudewijns; Ji Ma; Johan Neyts; Kai Dallmeier
Journal:  JHEP Rep       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.